GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » ROE %

MLAB (Mesa Laboratories) ROE % : 8.78% (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Mesa Laboratories's annualized net income for the quarter that ended in Sep. 2024 was $13.7 Mil. Mesa Laboratories's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was $156.1 Mil. Therefore, Mesa Laboratories's annualized ROE % for the quarter that ended in Sep. 2024 was 8.78%.

The historical rank and industry rank for Mesa Laboratories's ROE % or its related term are showing as below:

MLAB' s ROE % Range Over the Past 10 Years
Min: -98.39   Med: 1.06   Max: 14.12
Current: -98.39

During the past 13 years, Mesa Laboratories's highest ROE % was 14.12%. The lowest was -98.39%. And the median was 1.06%.

MLAB's ROE % is ranked worse than
96.49% of 2390 companies
in the Hardware industry
Industry Median: 4.34 vs MLAB: -98.39

Mesa Laboratories ROE % Historical Data

The historical data trend for Mesa Laboratories's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories ROE % Chart

Mesa Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 1.05 0.47 0.24 -94.36

Mesa Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.27 2.14 -371.41 9.15 8.78

Competitive Comparison of Mesa Laboratories's ROE %

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories's ROE % Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's ROE % distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's ROE % falls into.



Mesa Laboratories ROE % Calculation

Mesa Laboratories's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %=Net Income (A: Mar. 2024 )/( (Total Stockholders Equity (A: Mar. 2023 )+Total Stockholders Equity (A: Mar. 2024 ))/ count )
=-254.246/( (393.48+145.393)/ 2 )
=-254.246/269.4365
=-94.36 %

Mesa Laboratories's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %=Net Income (Q: Sep. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Sep. 2024 ))/ count )
=13.712/( (150.727+161.451)/ 2 )
=13.712/156.089
=8.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.


Mesa Laboratories  (NAS:MLAB) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=13.712/156.089
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(13.712 / 231.332)*(231.332 / 447.2295)*(447.2295 / 156.089)
=Net Margin %*Asset Turnover*Equity Multiplier
=5.93 %*0.5173*2.8652
=ROA %*Equity Multiplier
=3.07 %*2.8652
=8.78 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=13.712/156.089
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (13.712 / 15.248) * (15.248 / 14.032) * (14.032 / 231.332) * (231.332 / 447.2295) * (447.2295 / 156.089)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8993 * 1.0867 * 6.07 % * 0.5173 * 2.8652
=8.78 %

Note: The net income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Mesa Laboratories ROE % Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories Business Description

Traded in Other Exchanges
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Executives
Gary M Owens officer: COO 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Brian David Archbold officer: SVP of Continuous Improvement 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder director C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys officer: VP Finance, CFO MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin director 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny director ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia officer: SVP Commercial Operations 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/ director 12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan officer: VP Sales & Marketing 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly director
Shiraz Shabanali Ladiwala director C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer director 12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft director 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez director 12100 6TH AVENUE, LAKEWOOD CO 80228

Mesa Laboratories Headlines